These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37936510)

  • 21. The clinical usefulness of glucated haemoglobin in diabetes care evaluated by use of a medical technology assessment strategy.
    Larsen ML
    Dan Med Bull; 1997 Jun; 44(3):303-15. PubMed ID: 9233549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
    Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
    Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country.
    Alzubaidi H; Hasan S; Saidawi W; Mc Namara K; Chandir S; Krass I
    Diabet Med; 2021 Aug; 38(8):e14598. PubMed ID: 33969536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for type 2 diabetes: a short report for the National Screening Committee.
    Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
    Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial.
    Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K
    BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
    Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
    J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy.
    Schwab P; Racsa P; Rascati K; Mourer M; Meah Y; Worley K
    J Manag Care Spec Pharm; 2019 Mar; 25(3):332-340. PubMed ID: 30816817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus in a Semi-Urban Brazilian Population.
    do Vale Moreira NC; Montenegro RM; Meyer HE; Bhowmik B; Mdala I; Siddiquee T; Oliveira Fernandes V; Hussain A
    Int J Environ Res Public Health; 2019 Sep; 16(19):. PubMed ID: 31561434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of undiagnosed diabetes and pre-diabetes in chronic periodontitis patients assessed by an HbA1c chairside screening protocol.
    Mataftsi M; Koukos G; Sakellari D
    Clin Oral Investig; 2019 Dec; 23(12):4365-4370. PubMed ID: 30968241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of glycated haemoglobin (HbA1c) as a screening test for diabetes and impaired glucose tolerance (IGT) in a high risk population--the Brazilian Xavante Indians.
    Franco LJ; Dal Fabbro AL; Martinez EZ; Sartorelli DS; Silva AS; Soares LP; Franco LF; Kuhn PC; Vieira-Filho JP; Moisés RS
    Diabetes Res Clin Pract; 2014 Nov; 106(2):337-42. PubMed ID: 25271115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.
    Muktabhant B; Sanchaisuriya P; Sarakarn P; Tawityanon W; Trakulwong M; Worawat S; Schelp FP
    BMC Public Health; 2012 May; 12():349. PubMed ID: 22583817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editor's Choice- Diagnosis of type 2 diabetes and prediabetes among patients with acute coronary syndromes.
    Bjarnason TA; Kristinsdottir LB; Oskarsdottir ES; Hafthorsson SO; Olafsson I; Lund SH; Andersen K
    Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):744-749. PubMed ID: 27625341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice.
    Fellows SE; Cipriano GC
    P R Health Sci J; 2019 Sep; 38(3):189-191. PubMed ID: 31536634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-sectional comparison of point-of-care with laboratory HbA₁c in detecting diabetes in real-world remote Aboriginal settings.
    Marley JV; Oh MS; Hadgraft N; Singleton S; Isaacs K; Atkinson D
    BMJ Open; 2015 Mar; 5(3):e006277. PubMed ID: 25765020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of prediabetes among virally suppressed adults with HIV in Central Kenya detected using glycated haemoglobin and fasting blood glucose.
    Njoroge A; Augusto O; Page ST; Kigondu C; Oluka M; Puttkammer N; Farquhar C
    Endocrinol Diabetes Metab; 2021 Oct; 4(4):e00292. PubMed ID: 34505404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Diabetes Screening and Educational Event in Rural Alabama.
    Brown LG; Prather C
    Am J Nurs; 2020 Apr; 120(4):61-63. PubMed ID: 32218054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk-based prediabetes screening in a rural general practice - oral glucose tolerance test or glycated hemoglobin?].
    Galvács H; Szabó J; Balogh Z
    Orv Hetil; 2019 Dec; 160(50):1976-1983. PubMed ID: 31814420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.